Literature DB >> 8674282

HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer.

K Ogoshi1, T Tajima, T Mitomi, K Tsuji.   

Abstract

We investigated the association between human leucocyte antigen (HLA) antigens and lymph node metastasis in 724 gastric cancer patients. Among patients who had poorly differentiated adenocarcinoma with or without HLA-DR4 antigen, lymph node metastasis was detected in 80.8 and 54.9%, respectively (relative risk (RR) = 3.5, P = 0.0005, corrected P = 0.0285). It was more common in patients with a family history of cancer death (RR = 7.7). Among signet ring cell carcinoma patients with or without HLA-B52 antigen, lymph node metastasis was detected in 57.7 and 19.7%, respectively (RR = 5.6, P = 0.0001, corrected P = 0.0086). It was more common in patients who were smokers (RR= 8.3). Our findings suggest that HLA-DR4 and HLA-B52 antigens are associated with lymph node metastasis in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674282     DOI: 10.1007/bf00053901

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  12 in total

1.  An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma.

Authors:  D A Hilton; K P West
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

2.  HLA-DR4 antigen and lymph node metastases in poorly differentiated adenocarcinoma of the stomach.

Authors:  K Ogoshi; T Tajima; T Mitomi; K Tsuji
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

Review 3.  Teaching the immune system to fight cancer.

Authors:  T Boon
Journal:  Sci Am       Date:  1993-03       Impact factor: 2.142

4.  The general rules for the gastric cancer study in surgery ad pathology. Part II. Histological classification of gastric cancer.

Authors: 
Journal:  Jpn J Surg       Date:  1981-03

5.  Expression of HLA-class II antigen in gastric carcinomas. Its relationship to histopathological grade, lymphocyte infiltration and five-year survival rate.

Authors:  X C Ma; T Hattori; R Kushima; N Terata; M Kodama
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

6.  Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms.

Authors:  E Gorelik; M Kim; L Duty; T Henion; U Galili
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

7.  Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.

Authors:  J Gutierrez; M A López-Nevot; T Cabrera; R Oliva; J Esquivias; F Ruiz-Cabello; F Garrido
Journal:  Exp Clin Immunogenet       Date:  1987

8.  Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene.

Authors:  E R Fearon; T Itaya; B Hunt; B Vogelstein; P Frost
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

9.  Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.

Authors:  B Stein; F Momburg; V Schwarz; P Schlag; G Moldenhauer; P Möller
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

10.  Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.

Authors:  A Van Pel; F Vessière; T Boon
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  3 in total

1.  Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer.

Authors:  Karen Toledo-Stuardo; Carolina H Ribeiro; Andrea Canals; Marcela Morales; Valentina Gárate; Jose Rodríguez-Siza; Samantha Tello; Marco Bustamante; Ricardo Armisen; Douglas J Matthies; Gerald Zapata-Torres; Patricio González-Hormazabal; María Carmen Molina
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

2.  The increase of MICA gene A9 allele associated with gastric cancer and less schirrous change.

Authors:  S-S Lo; Y-J Lee; C-W Wu; C-J Liu; J-W Huang; W-Y Lui
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

3.  Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancer.

Authors:  Peixin Chen; Lishu Zhao; Hao Wang; Liping Zhang; Wei Zhang; Jun Zhu; Jia Yu; Sha Zhao; Wei Li; Chenglong Sun; Chunyan Wu; Yayi He; Caicun Zhou
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.